On Sample Size Calculation in Bioequivalence Trials

Sample size calculations plays an important role in a bioequivalence trials and is determined by considering power under the alternative hypothesis. The regulatory guideline recommends that $2{\times}2$ crossover design is conducted and raw data is log-transformed for statistical analysis. In this paper, we discuss the sample size calculation in $2{\times}2$ crossover design with the log-transformed data.